3 unknown, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 3, Terminated 1 |
Follow Adenomatous Polyposis Coli: new trials by email Literature Review of Adenomatous Polyposis Coli trials Research Report on Adenomatous Polyposis Coli
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Azithromycin Tablets - Familial Adenomatous Polyposis | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 10 | 2020-08-01 | 2020-07-01 |
| Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version Erythromycin - FAP-Familial Adenomatous Polyposis | Phase 4 | Unknown | michal roll | 15 | 2015-06-01 | 2015-02-03 |
| Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Erythromycin - FAP-Familial Adenomatous Polyposis | Phase 4 | Unknown | michal roll | 20 | 2014-06-01 | 2014-06-26 |
| A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) MK0966; rofecoxib / Duration of Treatment: 24 weeks, Comparator: placebo / Duration of Treatment: 24 weeks - Adenomatous Polyposis Coli | Phase 4 | Terminated | Merck Sharp & Dohme LLC | 62 | 2002-08-06 | 2019-09-20 |
Cancer Pain (1) · Osteoarthritis (1)
Adenoma (4) · Adenomatous Polyps (4) · Colonic Diseases (4) · Colorectal Neoplasms (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Genetic Diseases, Inborn (4) · Intestinal Diseases (4) · Intestinal Neoplasms (4) · Intestinal Polyposis (4) · Neoplasms (4) · Neoplasms by Histologic Type (4)
Erythromycin (2) · Azithromycin (1) · Duration of Therapy (1) · rofecoxib (1)
michal roll (2) · Merck Sharp & Dohme LLC (1) · Tel-Aviv Sourasky Medical Center (1)
Israel (2)
Revital Kariv, MD (1) · Revital Kariv, MD. (1) · Rina Rosin-Arbeseld, Ph.D (1) · Rina Rosin-Arbeseld, Ph.D. (1)